Dr.Reddy's news

Dr Reddy Laboratories News and Events : Find the latest news and events updates of Dr. Reddy's.

Srei posts Rs.26.58 crore net profit for second quarter

Srei posts Rs.26.58 crore net profit for second quarter

India Business Blog - 3 hours ago
by Indo Asian News Service on October 26, 2009 Dr.Reddy's Lab net profit rises 116.52 percent Hyderabad, Oct 23 (IANS) Pharma major Dr. Reddy's Laboratories Friday said its net profit for the ...

Canara Bank net profit up 72 percent in second quarter

Canara Bank net profit up 72 percent in second quarter

India Business Blog - 47 minutes ago
by Indo Asian News Service on October 26, 2009 Dr.Reddy's Lab net profit rises 116.52 percent Hyderabad, Oct 23 (IANS) Pharma major Dr. Reddy's Laboratories Friday said its net profit for the ...

Kareus Therapeutics announces addition of senior management

Kareus Therapeutics announces addition of senior management

Mass Media Distribution LLC - 57 minutes ago
Atlanta, GA (MMD Newswire) October 26, 2009 -- Kareus Therapeutics, LLC, an Atlanta based emerging drug discovery company today announced that Dr.Patrick Doyle has joined the company as President ...

Skindia GDR Index signals weak Nifty opening

Skindia GDR Index signals weak Nifty opening

Myiris.com - 29 minutes ago
The reduction in the premium of the Skindia GDR Index by 1.19% on Friday`s over previous close indicates a weak Nifty opening. The Skindia GDR Index closed 0.39% lower on 23rd October, 2009 at 2 ...

Dr Reddy's manages Sumatriptan exit well, beats estimates

Dr Reddy's manages Sumatriptan exit well, beats estimates

Livemint - 59 minutes ago
Most analysts expected Dr Reddy's Laboratories Ltd's US generics business to slow a bit in the September quarter. A key drug, Sumatriptan, was to lose marketing exclusivity, meaning competitors ...

Dr. Reddy Reports Solid 2Q

Dr. Reddy Reports Solid 2Q

Morningstar.ca - 1 hour ago
by Brian Laegeler | 23 Oct 09 | E-mail Article to a Friend We expect to modestly increase our fair value estimate for Dr. Reddy Laboratories RDY following solid second-quarter earnings. The ...

Syndicate content